Optigenex

OPGX · OTC

$0.0003+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About OPGX

Optigenex, Inc. is engaged in the manufacturing and licensing of beauty, dietary supplements, and personal care products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2005-04-15. The firm is focused on providing solutions for healthy age management. Its ac-11 is the patented compound that helps the body to repair its own deoxyribonucleic acid (DNA). Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The firm's technology helps the body’s natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation; maintains telomere length and integrity during the process of cellular mitosis, and increases production of natural collagen III.

Employees
0
Headquarters
Scottsdale, Arizona
Listed
Apr 15, 2005
Sector
Materials
Industry
Chemicals

Leadership

Optigenex executives
NameTitleSince
William Walters—2002
Daniel Zwiren——
Michael Mullarkey——

Similar companies

Companies in the same industry as Optigenex

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.